PSYCH is a data and insights platform for the psychedelic healthcare industry.

'Regulators, legislators, physicians, therapists—pretty much everyone...—has some fear. I used to feel that way too until I started looking closely at the data.'

Mason Marks, Senior Fellow at @Harvard_Law, spoke to @BMJ_latest on psilocybin's potential:

Psilocybin: a revolution in psychedelic medicines in the US?

As a flurry of US states approve psilocybin for medicinal use, Joanne Silberner asks whether the most carefully st...

bit.ly

‘This new centre aims to accelerate the integration of innovative models of care, including psilocybin therapy into the @NHSuk.'

@COMPASSPathway's CEO, Kabir Nath, spoke with @MetroUK on initiatives for publicly funded psychedelic healthcare: $CMPS

How psychedelics and tranquilisers could be the new therapy

The future is bright, but there is a barrier to these drugs and it is inertia.

bit.ly

In 2023, medical practitioners in Alberta will be able to apply for a license to conduct psychedelic-assisted therapy.

It is hoped regulatory reform at the state-level will instigate federal legalisation: via @CBCNews

Alberta to be 1st province to regulate psychedelics for therapy, government says | CBC News

Alberta will become the first Canadian jurisdiction to regulate the use of psychedelic drugs for people in therapy, the province announced Wednesday.

bit.ly